Skip to content

Transvaginal Pelvic Ultrasound in the ED

Transvaginal Pelvic Ultrasound in the ED

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02547857
Enrollment
114
Registered
2015-09-11
Start date
2015-09-30
Completion date
Unknown
Last updated
2016-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain, Pelvic Pain

Keywords

Pelvic ultrasound, Transvaginal ultrasound

Brief summary

Pelvic ultrasound is frequently performed in the ED in non-pregnant women to assess for ovarian pathology, though its use has not been described in the medical literature. This observational study aims to describe its use in clinical ED practice.

Detailed description

Pelvic ultrasound is frequently performed in the ED in non-pregnant women to assess for ovarian pathology. During the pelvic examination a transvaginal ultrasound probe is used to visualize ovarian size, determine echotexture, assess whether ovarian tenderness is present, and sometimes measure ovarian blood flow. Though pelvic ultrasound is used in the Hennepin County Medical Center ED routinely, there is a paucity of literature assessing it's utility. This observational study will help determine the usefulness of this imaging modality, and how often it changes management in clinical practice. Specifically, this study will attempt to determine how often transvaginal ultrasound identifies the structures of interest, and then will correlate these findings with the final ED diagnosis. If a formal ultrasound is obtained, the findings of the ED ultrasound will also be compared to the findings of the formal ultrasound. The treating physicians will be queried the diagnosis and management plans before and after the pelvic US to ascertain changes in management.

Interventions

OTHERPelvic US

To be eligible for inclusion, a woman will have pelvic US completed as part of her ED stay. This is a non-interventional study.

Sponsors

Hennepin Healthcare Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>= 18 years old female * ED bedside transvaginal ultrasound to be performed in a non-pregnant woman with at least one ovary * Willing to discuss how they are doing at 7-10 days via phone * Valid phone number

Exclusion criteria

* If a diagnosis of ovarian torsion, mass, TOA or other ovarian pathology is known before ED ultrasound * Previously enrolled in this study

Design outcomes

Primary

MeasureTime frameDescription
Change in diagnosis before/after pelvic US8 hours (or less, this will measure what occurs during an ED stay)The treating physician will be queried the likelihood of EMERGENT and NON-EMERGENT ovarian pathology before and after pelvic US using the following scale: Definite, Probable, Possible, Very Unlikely. The ED tests reviewed before each of these judgements will be noted. EMERGENT is defined as ovarian torsion or tubo-ovarian abscess (TOA). NON-EMERGENT is defined as all other causes, including ovarian cyst, ovarian mass, ovarian malignancy, adnexal mass). The clinician will also free text the most likely diagnosis. A change of two or more levels (eg definite to possible, definite to very unlikely, probable to very unlikely, or vice versa) will be assumed to be a significant change in diagnosis.
Change in management plan before/after pelvic US8 hours (or less, this will measure what occurs during an ED stay)The treating physician will choose from the following regarding the management plan before/after the pelvic US: outpatient referral to OB/GYN, formal pelvic US after bedside US, consult GYN in the ED, urgent/emergent operative intervention, None of the above. Any difference in management before/after pelvic US will be considered a significant change in management.

Secondary

MeasureTime frameDescription
Duration of pelvic US8 hours (or less, this will measure what occurs during an ED stay)Less than 5 minutes, 5-10 minutes, more than 10 minutes
Ovary enlargement8 hours (or less, this will measure what occurs during an ED stay)Were the ovaries larger than 3.5 x 2 cm in any plane? yes/no answer
Ovarian tenderness, sonographic8 hours (or less, this will measure what occurs during an ED stay)As a dichotomous yes/no. This will be correlated to final diagnosis. How many women with a non-tender ovary ended up with EMERGENT pathology? How many had NON-EMERGENT pathology?
Ovarian blood flow8 hours (or less, this will measure what occurs during an ED stay)The physician will determine if the ovarian flow is normal in a dichotomous yes/no answer. (if performed)
ED disposition after visit8 hours (or less, this will measure what occurs during an ED stay)This will measure if the patient is discharged from the ED or admitted to the hospital
Sonographic visualization of ovaries8 hours (or less, this will measure what occurs during an ED stay)yes/no
Correlation between ED US and Formal US8 hours (or less, this will measure what occurs during an ED stay)If a formal US is obtained, the reading will be abstracted and compared to the ED US for the following: ovary visualization, ovary size, ovarian flow, final diagnosis, and any other abnormality in free text.
Final impression for ED ultrasound with regards to ovaries8 hours (or less, this will measure what occurs during an ED stay)NORMAL or ABNORMAL. If abnormal, the abnormality will be described.
Formal pelvic US8 hours (or less, this will measure what occurs during an ED stay)Was this study obtained? dichotomous yes/no. And why was a formal pelvic US obtained? (abnormality of ovaries on bedside US; other abnormality on bedside US; unable to visualize ovaries on bedside US; good visualization of all structures and all structures normal, but post-test probability still high; Other (free text). )The exact reason will then be listed in free text.
Final ED diagnosis8 hours (or less, this will measure what occurs during an ED stay)Two questions will be answered: 1. Ovarian Pathology, Emergency (tubo-ovarian abscess, torsion) 2. Ovarian Pathology, Non-Emergency (cyst, mass, malignancy) 3. Non-ovarian problem Question 2: Final ED diagnosis after all work-up: (select all that apply) checkbox 1. ed\_final\_dx\_2\_\_\_1 ovarian cyst 2. ed\_final\_dx\_2\_\_\_2 ovarian mass 3. ed\_final\_dx\_2\_\_\_3 ovarian torsion 4. ed\_final\_dx\_2\_\_\_4 tubo-ovarian abscess 5. ed\_final\_dx\_2\_\_\_5 other ovarian pathology 6. ed\_final\_dx\_2\_\_\_6 adnexal mass (non-ovarian) 7. ed\_final\_dx\_2\_\_\_7 Pelvic Inflammatory Disease 8. ed\_final\_dx\_2\_\_\_8 Abdominal pathology (appendicitis, diverticulitis, SBO, others) 9. ed\_final\_dx\_2\_\_\_9 Non-specific abdominal pain 10. ed\_final\_dx\_2\_\_\_10 None of the above and no ovarian pathology suspected
7-day follow-up7 daysWhether another facility was visited, whether a procedure occurred, and what else happened during this stay. Patients will be attempted to be contacted three times.

Other

MeasureTime frameDescription
Method of finding ovaries8 hours (or less, this will measure what occurs during an ED stay)Will choose from: 1. Adjacent to pelvic vessels 2. Followed out from uterine cornu 3. No particular method used
Experience of sonographer8 hours (or less, this will measure what occurs during an ED stay)Choose from: 1. G1 2. G2 3. G3-G5 4. Physician Assistant (PA) 5. Attending 6. US tech
Pelvic physical exam characteristics8 hours (or less, this will measure what occurs during an ED stay)Was there tenderness on the exam (right/left adnexa, suprapubic region, no tenderness)? Were any masses felt? (right/left adnexa, suprapubic, no mass)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026